406 related articles for article (PubMed ID: 9241082)
1. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
[TBL] [Abstract][Full Text] [Related]
2. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
Li YX; Coucke PA; Li JY; Gu DZ; Liu XF; Zhou LQ; Mirimanoff RO; Yu ZH; Huang YR
Cancer; 1998 Aug; 83(3):449-56. PubMed ID: 9690537
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease.
Proulx GM; Caudra-Garcia I; Ferry J; Harris N; Greco WR; Kaya U; Chan A; Wang CC
Am J Clin Oncol; 2003 Feb; 26(1):6-11. PubMed ID: 12576916
[TBL] [Abstract][Full Text] [Related]
4. Primary lymphomas of the nasal cavity and paranasal sinuses.
Robbins KT; Fuller LM; Vlasak M; Osborne B; Jing BS; Velasquez WS; Sullivan JA
Cancer; 1985 Aug; 56(4):814-9. PubMed ID: 4016673
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of lymphomas involving Waldeyer's ring and the nasal cavity and paranasal sinuses.
Robbins KT; Kong JS; Fuller LM; Goepfert H
J Otolaryngol; 1985 Feb; 14(1):7-13. PubMed ID: 4068097
[TBL] [Abstract][Full Text] [Related]
7. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
8. Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity. A report of 18 cases with stage IE disease.
Tran LM; Mark R; Fu YS; Calcaterra T; Juillard G
Am J Clin Oncol; 1992 Jun; 15(3):222-5. PubMed ID: 1590274
[TBL] [Abstract][Full Text] [Related]
9. Stage III follicular lymphoma: long-term follow-up and patterns of failure.
Ha CS; Kong JS; McLaughlin P; Tucker SL; Fayad LE; Hess MA; Wilder RB; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):748-54. PubMed ID: 14529780
[TBL] [Abstract][Full Text] [Related]
10. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality.
Cheung MM; Chan JK; Lau WH; Ngan RK; Foo WW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):182-90. PubMed ID: 12182990
[TBL] [Abstract][Full Text] [Related]
11. Malignant tumors of the nasal cavity and paranasal sinuses.
Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB
Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046
[TBL] [Abstract][Full Text] [Related]
12. [Non-Hodgkin's lymphoma of the nasal cavity and paranasal sinuses: clinicopathologic study of ten cases].
Chubachi A; Miura AB; Nishimura S; Akihama T; Kuwayama A; Saitoh M; Watanuki T
Rinsho Ketsueki; 1991 Jun; 32(6):675-80. PubMed ID: 1890745
[TBL] [Abstract][Full Text] [Related]
13. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review.
Dulguerov P; Jacobsen MS; Allal AS; Lehmann W; Calcaterra T
Cancer; 2001 Dec; 92(12):3012-29. PubMed ID: 11753979
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's malignant lymphoma of the sinonasal tract--treatment outcome for 53 patients according to REAL classification.
Hatta C; Ogasawara H; Okita J; Kubota A; Ishida M; Sakagami M
Auris Nasus Larynx; 2001 Jan; 28(1):55-60. PubMed ID: 11137364
[TBL] [Abstract][Full Text] [Related]
15. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
16. [Management and prognosis of patients with squamous cell carcinomas of the nasal cavity and the paranasal sinuses].
Pickhard A; Durst F; Staudenmaier R; Reiter R
Laryngorhinootologie; 2012 Oct; 91(10):627-32. PubMed ID: 22930278
[TBL] [Abstract][Full Text] [Related]
17. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome of nasal and paranasal sinus carcinoma.
Hicsonmez A; Andrieu MN; Karaca M; Kurtman C
J Otolaryngol; 2005 Dec; 34(6):379-83. PubMed ID: 16343397
[TBL] [Abstract][Full Text] [Related]
19. Treatment of non-Hodgkin lymphomas in the nasal cavities and paranasal sinuses. A failure analysis.
Kondo M; Mikata A; Inuyama Y; Uematsu M; Shigematsu N; Nishiguchi I; Hashimoto S
Acta Radiol Oncol; 1986; 25(2):91-7. PubMed ID: 3012963
[TBL] [Abstract][Full Text] [Related]
20. Nonsquamous cell malignant neoplasms of the nasal cavities and paranasal sinuses.
Spiro JD; Soo KC; Spiro RH
Head Neck; 1995; 17(2):114-8. PubMed ID: 7558807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
